Found 10 bookmarks
Custom sorting
Alterations of the amygdala in post-COVID olfactory dysfunction
Alterations of the amygdala in post-COVID olfactory dysfunction

University Hospital Schleswig-Holstein, 61 adults about 8 months after COVID were scanned by MRI.

Those with persistent smell loss showed structural changes in the amygdala linked to smell and emotion, along with higher anxiety and depression scores.

·nature.com·
Alterations of the amygdala in post-COVID olfactory dysfunction
Neuropsychiatric Risks Linked to COVID-19 Revealed
Neuropsychiatric Risks Linked to COVID-19 Revealed

New Nature study shows SARS2 significantly elevates the risk of neuropsychiatric conditions including anxiety, mood disorders, cognitive impairment and psychotic disorders for up to 6 months.

“Alarmingly, even individuals with mild or asymptomatic infections face elevated risk.”

·bioengineer.org·
Neuropsychiatric Risks Linked to COVID-19 Revealed
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection

“COVID-19 survivors were at higher adjusted risk of mortality, major adverse cardiovascular events, fatigue, sleep disturbance, and dyspnea. • COVID-19 may be a risk factor for onset of symptoms and adverse events in patients with neurological conditions”

COVID-19 survivors were at higher adjusted risk of mortality, major adverse cardiovascular events, fatigue, sleep disturbance, and dyspnea.•COVID-19 may be a risk factor for onset of symptoms and adverse events in patients with neurological conditions
·sciencedirect.com·
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection
Vaccination Does Not Impact Long COVID Neurological Symptoms
Vaccination Does Not Impact Long COVID Neurological Symptoms
“Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute sequelae of SARS-CoV-2 infection, according to a study published online Jan. 7 in Brain Communications”
Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute sequelae of SARS-CoV-2 infection, according to a study published online Jan. 7 in Brain Communications.Shreya Mukherjee, from the Northwestern University Feinb
·healthday.com·
Vaccination Does Not Impact Long COVID Neurological Symptoms
How COVID Might Sow Chaos in the Brain
How COVID Might Sow Chaos in the Brain

How COVID Might Sow Chaos in the Brain

SARS-CoV-2 appears to travel widely across the cerebral cortex

Headaches, hallucinations, vivid dreams, smell & taste anomalies, strokes and seizures

80% of COVID patients encountered neurological complications

·scientificamerican.com·
How COVID Might Sow Chaos in the Brain
Long COVID Breakthrough: Spike Proteins Persist in Brain for Years
Long COVID Breakthrough: Spike Proteins Persist in Brain for Years
“A study reveals that the spike protein of SARS-CoV-2 remains in the brain long after infection, causing potential neurological issues and accelerated brain aging. mRNA vaccines help lower this risk but are not completely effective in eliminating the protein.”
A study reveals that the spike protein of SARS-CoV-2 remains in the brain long after infection, causing potential neurological issues and accelerated brain aging. mRNA vaccines help lower this risk but are not completely effective in eliminating the protein.
·scitechdaily.com·
Long COVID Breakthrough: Spike Proteins Persist in Brain for Years
Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis - BMC Geriatrics
Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis - BMC Geriatrics
“11 studies (involving 939,824 post-COVID-19 survivors and 6,765,117 controls) were included in the review. Across a median observation period of 12 months post-COVID, the overall incidence of NOD was about 1.82% in the COVID-infected group, compared to 0.35% in the non-COVID-infected group. The overall pooled meta-analysis showed a significantly increased NOD risk among COVID-19 older adult survivors compared to non-COVID-19 controls”
11 studies (involving 939,824 post-COVID-19 survivors and 6,765,117 controls) were included in the review. Across a median observation period of 12 months post-COVID, the overall incidence of NOD was about 1.82% in the COVID-infected group, compared to 0.35% in the non-COVID-infected group. The overall pooled meta-analysis showed a significantly increased NOD risk among COVID-19 older adult survivors compared to non-COVID-19 controls
·bmcgeriatr.biomedcentral.com·
Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis - BMC Geriatrics